FDA accepts BLA for Lucentis referencing ophthalmology biosimilar SB11
Samsung Bioepis and Biogen said that the US Food and Drug Administration (FDA) has accepted for review the biologics license application for SB11, a proposed ophthalmology biosimilar referencing Genentech’s Lucentis (ranibizumab). Ranibizumab is an anti vascular endothelial growth factor (VEGF) therapy for retinal vascular disorders, which are a major cause of blindness in the US. […]
Belgian pharma company UCB has signed a global exclusive license deal worth up to $2 billion for its Alzheimer’s Disease drug candidate (AD drug candidate) UCB0107 with Roche and its subsidiary Genentech. UCB0107 is a monoclonal antibody drug candidate, which is being developed by UCB as a potential therapy for patients with progressive supranuclear palsy […]
Continue reading …
Swiss pharma giant Roche and US precision therapy company Blueprint Medicines have entered into a worldwide licensing and collaboration deal potentially worth up to $1.703 billion for the latter’s cancer drug candidate pralsetinib. Through the deal, Roche gains exclusive rights for the co-development and marketing of the investigational drug for RET-altered cancers across the world […]
Continue reading …
California-based healthcare company Clover Health has launched a new research subsidiary, called Clover Therapeutics, which will focus on developing drugs for older adults for the treatment of chronic diseases. Clover Therapeutics has started its journey by signing a research collaboration and license agreement with Roche’s subsidiary Genentech to better understand the genomic factors that increase […]
Continue reading …
Roche Group’s subsidiary Genentech has secured the US FDA approval for its multiple sclerosis drug, Ocrevus (ocrelizumab) for treating both relapsing and primary progressive variants of the chronic disease through intravenous infusion. The FDA approval has made the Genentech MS drug Ocrevus as the first and only therapy available for the two forms of multiple […]
Continue reading …
Business News Today
- Scanpoint Geomatics wins contract from BiharShariff Smart City
- Arbuthnot Banking sells Tay mortgage portfolio to OneSavings Bank
- Clothing retailer Gap to open $140m Customer Experience Center in Longview
- Kiwi insurer Tower to acquire legacy portfolio of ANZ
- World Insurance Associates acquires Corporate Risk Services in Arkansas
- Roivant Sciences to acquire Silicon Therapeutics to boost drug discovery capabilities
- Kotak Mahindra Bank acquires stake in new fintech company Ferbine
- Infosys to expand Pennsylvania Retirement Services Center of Excellence
- Energean takes full ownership of Israeli subsidiary
- Merck to acquire US biotech company Pandion Therapeutics for $1.8bn